Prognostic value of asymmetric dimethylarginine for the course of acute myocardial infarction combined with type 2 diabetes mellitus
| dc.contributor.author | Feldman, Diana | |
| dc.contributor.author | Фельдман, Діана Аркадіївна | |
| dc.contributor.author | Ryndina, Natalia | |
| dc.contributor.author | Риндіна, Наталія Геннадіївна | |
| dc.date.accessioned | 2020-11-23T19:04:58Z | |
| dc.date.available | 2020-11-23T19:04:58Z | |
| dc.date.issued | 2020-10 | |
| dc.description.abstract | Today, acute myocardial infarction (AMI) is the leading cause of death and disability of the able-bodied population in most countries of the world. The course and prognosis of AMI depend on the presence of comorbid pathology. Type 2 diabetes mellitus (DM) is the cause that determines the unfavorable AMI course. | en_US |
| dc.identifier.citation | Feldman D. Prognostic value of asymmetric dimethylarginine for the course of acute myocardial infarction combined with type 2 diabetes mellitus / D. Feldman, N. Ryndina // ISIC-2020 : [International Scientific Interdisciplinary Conference for medical students and young scientists, Kharkiv, 8–9 October, 2018] : abstract book / KNMU. – Kharkiv, 2020. – P. 66. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/27472 | |
| dc.language.iso | en | en_US |
| dc.subject | miocardial infarction | en_US |
| dc.subject | type 2 diabetes mellitus | en_US |
| dc.title | Prognostic value of asymmetric dimethylarginine for the course of acute myocardial infarction combined with type 2 diabetes mellitus | en_US |
| dc.type | Thesis | en_US |